CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH Date & Time:
- Tuesday, July 11, 2023, 2-3 PM ET
Speaker:
- Gary Goldenberg, MD, Assistant Clinical Professor, Dermatology, Icahn School of Medicine at Mount Sinai Hospital, Chief Medical Officer, Verrica Pharmaceuticals Inc.
Webinar Description:
- This webinar will focus on VP-102, an investigational drug being reviewed by the FDA for the treatment of molluscum contagiosum. The safety and efficacy of VP-102 has not been established.
- The Company’s NDA for VP-102 was resubmitted to the FDA in January, 2023 and assigned a PDUFA goal date of July 23, 2023.
- The 505(b)(1) NDA was supported by positive results from two identical, double-blind, randomized Phase 3 trials (CAMP-1 and CAMP-2) that evaluated the safety and efficacy of VP-102 compared to vehicle in patients.
Dermatology Latest Posts
- Penile Lesions in a Healthy 3-Year-Old Boy
- 7 Long-term Health Effects of Psoriasis
- Acne Fulminans
- Salt-and-pepper Skin Pigmentation
Did You Know?
Molluscum contagiosum affects approximately 6 million people in the US each year, predominantly children.
